50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
CEO of biggest PE firm predicts “social unrest” (Ad)
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
German leader continues Gulf tour with stops in UAE, Qatar
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Labour conference starts with focus on 'immoral' tax cuts
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
CEO of biggest PE firm predicts “social unrest” (Ad)
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
German leader continues Gulf tour with stops in UAE, Qatar
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Labour conference starts with focus on 'immoral' tax cuts
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
CEO of biggest PE firm predicts “social unrest” (Ad)
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
German leader continues Gulf tour with stops in UAE, Qatar
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Labour conference starts with focus on 'immoral' tax cuts
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
CEO of biggest PE firm predicts “social unrest” (Ad)
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
German leader continues Gulf tour with stops in UAE, Qatar
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Labour conference starts with focus on 'immoral' tax cuts
Poverty and inflation: Egypt's economy hit by global turmoil
TSE:BHC

Bausch Health Companies - BHC Stock Forecast, Price & News

C$9.56
-0.07 (-0.73%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
C$9.06
C$9.60
50-Day Range
C$5.50
C$11.83
52-Week Range
C$5.10
C$37.38
Volume
1.81 million shs
Average Volume
1.02 million shs
Market Capitalization
C$3.46 billion
P/E Ratio
50.32
Dividend Yield
N/A
Price Target
C$29.00

Bausch Health Companies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
203.3% Upside
C$29.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of Bausch Health Companies in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
C$983,535 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

BHC stock logo

About Bausch Health Companies (TSE:BHC) Stock

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

Why Is Bausch (BHC) Up 23% Since Last Earnings Report?
Bausch Health: How To Price The Calamities
See More Headlines
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Company Calendar

Last Earnings
8/09/2022
Today
9/25/2022
Next Earnings (Estimated)
11/01/2022

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
19,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$29.00
High Stock Price Forecast
C$32.00
Low Stock Price Forecast
C$26.00
Forecasted Upside/Downside
+203.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8.19 billion
Cash Flow
C$1.82 per share
Book Value
C($1.92) per share

Miscellaneous

Free Float
N/A
Market Cap
C$3.46 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Thomas J. Appio (Age 60)
    CEO & Director
    Comp: $2.9M
  • Mr. Thomas G. Vadaketh (Age 59)
    Exec. VP & CFO
  • Mr. Mirza Dautbegovic
    Sr. VP & COO
  • Mr. John S. Barresi (Age 49)
    Sr. VP, Controller & Chief Accounting Officer
  • Dr. Robert F. Butz
    VP of Medical & Scientific Affairs
  • Mr. Arthur J. Shannon
    Sr. VP and Head of Investor Relations & Global Communications
  • Ms. Seana Carson (Age 50)
    Exec. VP & Gen. Counsel
  • Ms. Kathleen Fitzpatrick
    Sr. VP & Chief HR Officer
  • Dr. Tage Ramakrishna M.D. (Age 48)
    Chief Medical Officer and Pres of R&D
  • Mr. Jeff Hartness
    Sr. VP of Market Access, Commercial Operations & Gov. Affairs













BHC Stock - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BHC shares.
View BHC analyst ratings
or view top-rated stocks.

What is Bausch Health Companies' stock price forecast for 2022?

1 Wall Street analysts have issued 1 year price targets for Bausch Health Companies' stock. Their BHC share price forecasts range from C$26.00 to C$32.00. On average, they predict the company's stock price to reach C$29.00 in the next twelve months. This suggests a possible upside of 203.3% from the stock's current price.
View analysts price targets for BHC
or view top-rated stocks among Wall Street analysts.

How have BHC shares performed in 2022?

Bausch Health Companies' stock was trading at C$34.94 at the beginning of 2022. Since then, BHC stock has decreased by 72.6% and is now trading at C$9.56.
View the best growth stocks for 2022 here
.

When is Bausch Health Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our BHC earnings forecast
.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc. (TSE:BHC) released its quarterly earnings results on Tuesday, August, 9th. The company reported $0.71 earnings per share for the quarter, missing analysts' consensus estimates of $1.15 by $0.44. The business had revenue of $2.51 billion for the quarter, compared to analysts' expectations of $2.63 billion.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), Nutrien (NTR), Suncor Energy (SU) and ARC Resources (ARX).

What is Bausch Health Companies' stock symbol?

Bausch Health Companies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BHC."

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Bausch Health Companies' stock price today?

One share of BHC stock can currently be purchased for approximately C$9.56.

How much money does Bausch Health Companies make?

Bausch Health Companies (TSE:BHC) has a market capitalization of C$3.46 billion and generates C$8.19 billion in revenue each year.

How many employees does Bausch Health Companies have?

The company employs 19,600 workers across the globe.

How can I contact Bausch Health Companies?

Bausch Health Companies' mailing address is 2150 Saint-Elzear Blvd W, Laval, Quebec H7L 4A8. The official website for the company is www.valeant.com. The company can be reached via phone at 514-744-6792.

This page (TSE:BHC) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.